Post-Bronchoscopy BAL Documentation
Your post-bronchoscopy note for BAL must include procedural details, specimen handling, immediate findings, and post-procedure monitoring to ensure proper clinical interpretation and patient safety.
Essential Procedural Components
Pre-Procedure Documentation
- Patient identification and indication: Document the specific clinical question (e.g., suspected ILD, infection, malignancy) that prompted the BAL 1
- HRCT timing and target site selection: Note that HRCT was performed within 6 weeks of the procedure and specify which bronchopulmonary segment was targeted based on imaging findings 1
- Baseline vital signs and oxygen saturation: Record pre-procedure SpO2, heart rate, blood pressure, and supplemental oxygen requirements 2
- Sedation administered: Document type, dose, and timing of sedatives and local anesthetics (lignocaine should not exceed 8.2 mg/kg) 2
Intra-Procedure Technical Details
- Bronchoscope position: Confirm wedge position within the selected bronchopulmonary segment 1
- Instillation volume: Record total volume of normal saline instilled (should be 100-300 mL divided into 3-5 aliquots) 1
- Recovery volume and percentage: Document total volume retrieved and calculate percentage recovered (optimal >30%, acceptable >5% per aliquot) 1
- Critical threshold: If <5% of each aliquot is recovered, note that the procedure was aborted to prevent tissue injury 1
- Gross appearance of BAL fluid: Describe color and consistency, as this provides immediate diagnostic clues 1
Specimen Processing Documentation
- Aliquot pooling: Note whether all aliquots were pooled (acceptable for routine analysis) or if the first aliquot was processed separately 1
- Transport method and timing: Document how specimens were transported to the laboratory 1
- Laboratory tests ordered: Specify all analyses requested 1
Post-Procedure Monitoring and Complications
Immediate Post-Procedure Assessment
- Vital signs: Record oxygen saturation, heart rate, blood pressure, and respiratory rate immediately after the procedure 2
- Supplemental oxygen requirements: Document any changes in oxygen needs 2
- Complications during procedure: Note any adverse events such as:
Post-Procedure Imaging
- Chest radiograph timing: Obtain chest X-ray at least 1 hour after BAL if transbronchial biopsy was performed to exclude pneumothorax 2
- Expected radiographic changes: Recognize that transient consolidation corresponding to the lavaged site is common and benign, typically clearing within 24 hours 5
Patient Instructions
- Delayed pneumothorax warning: Provide verbal and written advice about the possibility of delayed pneumothorax if transbronchial biopsy was performed 2
- Follow-up plan: Document when and how results will be communicated to the patient 2
Interpretation Framework
Expected Cellular Patterns in ILD
Document anticipated findings based on clinical context 1:
- Lymphocytic pattern: >15% lymphocytes (suggests hypersensitivity pneumonitis, sarcoidosis, organizing pneumonia) 1
- Neutrophilic pattern: >3% neutrophils (suggests acute interstitial pneumonia, infection, IPF) 1
- Eosinophilic pattern: >1% eosinophils (suggests eosinophilic pneumonia, drug reaction, parasitic infection) 1
- Normal pattern: Predominance of macrophages with <15% lymphocytes, <3% neutrophils, <1% eosinophils 1
Common Pitfalls to Avoid
- Do not interpret BAL in isolation: Cellular analysis alone is insufficient for specific ILD diagnosis except in malignancies and rare conditions like PAP 1
- Recognize procedure-induced inflammation: Serial BAL within 72 hours will show artifactual neutrophil recruitment, with peak elevation at 7 hours post-procedure 6
- Account for inadequate sampling: Total retrieved volume <30% of instilled volume may provide misleading differential cell counts, especially if <10% recovered 1
- Do not freeze specimens: BAL fluid should never be frozen or transported with dry ice, as this destroys cellular integrity 1
Sample Documentation Template
Procedure: Flexible bronchoscopy with bronchoalveolar lavage
Indication: [Specific clinical question, e.g., suspected ILD with ground-glass opacities on HRCT]
HRCT date: [Within 6 weeks of procedure]
Target site: [Specific bronchopulmonary segment based on HRCT findings]
Sedation: [Agent, dose, route]
Technique: Bronchoscope wedged in [segment]. Total 150 mL normal saline instilled in 3 aliquots of 50 mL each. Total 60 mL retrieved (40% recovery).
Gross appearance: [Clear/bloody/milky/cloudy]
Specimens sent: Differential cell count, PAS stain, bacterial/fungal/AFB cultures, [other tests]
Transport: Delivered to lab within 30 minutes at room temperature
Complications: None. SpO2 remained >92% throughout. No desaturation episodes.
Post-procedure: Stable vital signs. Supplemental O2 continued at baseline rate. CXR [if applicable] shows expected consolidation at lavage site. Patient counseled regarding results timeline and delayed pneumothorax precautions [if TBB performed].